Amitriptyline is a tricyclic antidepressant primarily prescribed to treat major depressive disorder, neuropathic pain, and for migraine prophylaxis. Laboratories utilize this collection of Amitriptyline… Read more
![Chemical structure of (E)-5-(3-(Dimethylamino)propylidene)-10,11-dihydro-5H-dibenzo[a,d][7]annulen-10-ol;](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F64520-05-4-E-5-3-Dimethylaminopropylidene-1011-dihydro-5H-dibenzoad7annulen-10-ol.png&w=3840&q=75)


![Chemical structure of 10,11-Dihydro-5H-dibenzo[a,d]cycloheptene](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F833-48-7-1011-Dihydro-5H-dibenzoadcycloheptene.png&w=3840&q=75)
![Chemical structure of 2,3,4,4a,11,11a-Hexahydro-1H-dibenzo[a,d][7]annulen-5(10H)-one](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F7351-59-9-2344a1111a-Hexahydro-1H-dibenzoad7annulen-510H-one.png&w=3840&q=75)
![Chemical structure of 2-(Ethyl-1-d)dibenzo[b,f]thiepin-10(11H)-one](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F2639262-13-6-2-Ethyl-1-ddibenzobfthiepin-1011H-one.png&w=3840&q=75)



![Chemical structure of 5-(3-(Dimethylamino)propyl)-2,3,4,4a,5,10,11,11a-octahydro-1H-dibenzo[a,d][7]annulen-5-ol](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F5-3-Dimethylaminopropyl-2344a5101111a-octahydro-1H-dibenzoad7annulen-5-ol.png&w=3840&q=75)
















Amitriptyline is a tricyclic antidepressant primarily prescribed to treat major depressive disorder, neuropathic pain, and for migraine prophylaxis. Laboratories utilize this collection of Amitriptyline reference standards to facilitate robust pharmaceutical testing and quality control. The selection includes pharmacopeial impurities and degradation products essential for accurate impurity profiling and analytical method development. Furthermore, the catalog features a range of stable isotope labelled compounds, including deuterated and 13C-labelled analogs, which are critical for the precise quantification of metabolites in biological matrices during bioanalytical method validation. By providing access to these well-characterized related substances, including synthetic intermediates and N-glucuronide metabolites, researchers can ensure compliance with regulatory standards for batch release and stability testing. This comprehensive range supports the maintenance of quality protocols for this therapeutic agent.